USD 6.42
(-10.71%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 10.2 Million USD | -27.92% |
2022 | 14.15 Million USD | 43.57% |
2021 | 9.86 Million USD | 602.42% |
2020 | 1.4 Million USD | 63.83% |
2019 | 857 Thousand USD | -89.76% |
2018 | 8.37 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 10.58 Million USD | 3.66% |
2024 Q2 | 9.68 Million USD | -8.44% |
2023 Q1 | 13.27 Million USD | -6.22% |
2023 Q2 | 12.16 Million USD | -8.37% |
2023 FY | 10.2 Million USD | -27.92% |
2023 Q4 | 10.2 Million USD | -7.42% |
2023 Q3 | 11.02 Million USD | -9.39% |
2022 Q2 | 16.05 Million USD | -0.52% |
2022 Q1 | 16.13 Million USD | 63.63% |
2022 Q4 | 14.15 Million USD | -7.03% |
2022 Q3 | 15.23 Million USD | -5.13% |
2022 FY | 14.15 Million USD | 43.57% |
2021 Q1 | - USD | -100.0% |
2021 Q2 | 14.31 Million USD | 0.0% |
2021 Q3 | 11.61 Million USD | -18.87% |
2021 Q4 | 9.86 Million USD | -15.09% |
2021 FY | 9.86 Million USD | 602.42% |
2020 Q4 | 1.4 Million USD | 0.0% |
2020 FY | 1.4 Million USD | 63.83% |
2020 Q1 | - USD | 0.0% |
2019 Q2 | 17.64 Million USD | 32.12% |
2019 FY | 857 Thousand USD | -89.76% |
2019 Q3 | 23.5 Million USD | 33.24% |
2019 Q1 | 13.35 Million USD | 59.56% |
2018 Q2 | 102 Thousand USD | 0.0% |
2018 Q3 | 2.91 Million USD | 2761.76% |
2018 Q4 | 8.37 Million USD | 186.74% |
2018 FY | 8.37 Million USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -113.111% |
Safety Shot Inc | 1.86 Million USD | -445.878% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 93.29% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 90.822% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -50.776% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 68.434% |
Dynavax Technologies Corporation | 53.29 Million USD | 80.848% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 84.448% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 12.372% |
Pacira BioSciences, Inc. | 104.35 Million USD | 90.22% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -77.967% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -77.967% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1160.378% |
Alpha Teknova, Inc. | 11.59 Million USD | 11.972% |
Procaps Group, S.A. | 96.83 Million USD | 89.46% |
Theratechnologies Inc. | 6.06 Million USD | -68.249% |
Harrow Health, Inc. | 10.86 Million USD | 6.083% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -275.359% |
Biofrontera Inc. | 10.9 Million USD | 6.436% |
DURECT Corporation | 2.21 Million USD | -359.937% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 86.815% |
Cronos Group Inc. | 30.33 Million USD | 66.36% |
OptiNose, Inc. | 8.05 Million USD | -26.751% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1020599900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -79.083% |
Organogenesis Holdings Inc. | 28.25 Million USD | 63.876% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -281.232% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -121.419% |
Radius Health, Inc. | 278.64 Million USD | 96.337% |
Universe Pharmaceuticals INC | 3.34 Million USD | -205.27% |
ProPhase Labs, Inc. | 3.84 Million USD | -165.712% |
Phibro Animal Health Corporation | 265.91 Million USD | 96.162% |
Procaps Group S.A. | 96.83 Million USD | 89.46% |
Alvotech | 74.43 Million USD | 86.288% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.706% |
Rockwell Medical, Inc. | 5.87 Million USD | -73.838% |
Aytu BioPharma, Inc. | 12.63 Million USD | 19.212% |
SIGA Technologies, Inc. | 64.21 Million USD | 84.107% |
Tilray Brands, Inc. | 252.08 Million USD | 95.951% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 74.472% |
Shineco, Inc. | 1.58 Million USD | -542.483% |
PetIQ, Inc. | 159.3 Million USD | 93.594% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 6780.281% |
Incannex Healthcare Limited | -10.01 Million USD | 201.907% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 73.352% |
Alimera Sciences, Inc. | 1.87 Million USD | -443.161% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 72.918% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -533.759% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -127.66% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -3912.55% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 1.676% |
Hempacco Co., Inc. | 2.54 Million USD | -301.396% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 86.288% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 78.646% |
Lantheus Holdings, Inc. | 64.02 Million USD | 84.06% |
Currenc Group, Inc. | 732.91 Thousand USD | -1292.529% |
Kamada Ltd. | 87.74 Million USD | 88.369% |
Indivior PLC | 141.79 Million USD | 92.803% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -2018.13% |
Flora Growth Corp. | 8.5 Million USD | -19.958% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -3912.55% |
Evolus, Inc. | 10.99 Million USD | 7.201% |
HUTCHMED (China) Limited | 50.25 Million USD | 79.693% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 90.357% |
Akanda Corp. | 1.28 Million USD | -693.072% |